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ABSTRACT
There is a spectrum/continuum of adult human wound healing outcomes ranging
from the enhanced (nearly scarless) healing observed in oral mucosa to scarring
within skin and the nonhealing of chronic skin wounds. Central to these outcomes is
the role of the fibroblast. Global gene expression profiling utilizing microarrays is
starting to give insight into the role of such cells during the healing process, but no
studies to date have produced a gene signature for this wound healing continuum.
Microarray analysis of adult oral mucosal fibroblast (OMF), normal skin fibroblast
(NF), and chronic wound fibroblast (CWF) at 0 and 6 hours post-serum stimulation
was performed. Genes whose expression increases following serum exposure in the
order OMF < NF < CWF are candidates for a negative/impaired healing phenotype
(the dysfunctional healing group), whereas genes with the converse pattern are
potentially associated with a positive/preferential healing phenotype (the enhanced
healing group). Sixty-six genes in the enhanced healing group and 38 genes in the
dysfunctional healing group were identified. Overrepresentation analysis revealed
pathways directly and indirectly associated with wound healing and aging and addi-
tional categories associated with differentiation, development, and morphogenesis.
Knowledge of this wound healing continuum gene signature may in turn assist in the
therapeutic assessment/treatment of a patient’s wounds.
The spectrum of wound healing outcomes within an adult
human ranges from the enhanced healing observed within
the oral mucosa (which has similarities with fetal scarless
healing/regeneration) to scarring in normal adult tissues, to
nonhealing chronic wounds in the aged. Fibroblasts are
central to a successful wound healing response, and altera-
tions in fibroblast functionality across an age-related con-
tinuum of wound healing functionality may enhance,
facilitate, or prevent normal wound healing and result in dif-
ferential wound healing processes and outcomes.
It is well established through in vitro investigations that oral
mucosal fibroblasts (OMFs) (compared with patient-matched
skin fibroblasts) exhibit a fetal-like phenotype.1,2 At the other
end of this continuum is the impaired wound healing pheno-
type shown by senescent fibroblasts found within chronic
(nonhealing) wounds of aged individuals. The response of
CWF Chronic wound fibroblast
CXCL Chemokine ligand
DAVID Database for Annotation, Visualization and Integrated
Discovery
EASE Expression Analysis of Systematic Explorer
ECM Extracellular matrix
FDR False discovery rate
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PAI Plasminogen activator inhibitor
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PDGF Platelet-derived growth factor
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these cells is impaired3,4 and in stark contrast to those from the
oral mucosa. Interestingly, impaired wound healing is also a
feature of certain premature aging conditions, for example,
Werner’s syndrome.5 Between these two extremes of tissue
response, the normal wound healing response, as found in adult
dermal tissues, features an intermediate rate of wound repair,
which results ultimately in a repair of the tissue but inevitably
the production of scar tissue (Figure 1).
The use of microarray technologies to carry out genome-
wide analysis of gene expression has been used to produce
gene signatures for skin from young and old individuals6 and
expression profiles of several different cell types isolated from
healthy skin.7 This technology has also been utilized to
compare skin cells (fibroblasts) from multiple anatomical
locations.8 Analysis of both acute9 and chronic wound gene
signatures has also been undertaken.6,10,11 Initial analysis of
the transcriptional response of cultured human fibroblasts to
serum showed that it mirrors many aspects of the normal
wound healing response.12 Analysis of this wound healing/
serum response in fibroblasts isolated from multiple anatomi-
cal sites leads to the description of a “core/common serum
response” signature of genes whose differential expression
pattern was shared.13 Research has started to identify gene
expression profiles associated with wound healing through in
vitro4,14,15 and in vivo10,11 studies. Such information is begin-
ning to generate insight into the wound healing process, to
identify potential prognostic indicators16 and also to aid clini-
cal decision making.10
In this study, we investigated the presence/absence of a
pattern of gene expression that may correlate to the “con-
tinuum” of wound healing phenotypes observed, spanning
enhanced (adult oral mucosa), normal (adult skin), and
impaired (adult chronic venous leg ulcers) wound healing in
order to get insight into the genes and processes involved. In
the future, this (wound healing-related) expression informa-
tion and the markers identified in this way may be helpful in
assessing the “status” of healing within a clinical wound and
to custom develop appropriate treatment regimes.
MATERIALS AND METHODS
Patients and tissues
Fibroblasts (n = 4) were established from either oral (buccal)
mucosa (OMF) and patient-matched skin from the head/neck
region (normal skin fibroblast [NF]1) or chronic venous leg
ulcer wound tissues (chronic wound fibroblast [CWF]) and
patient-matched “normal” skin (NF2) cultured from the
ipsilateral thigh, respectively (see Supporting Information
Table S1 for tissue details). All tissue samples (6 mm biopsy)
were obtained after South East Wales Research Ethics Com-
mittee approval and written informed patient consent either
from patients attending for minor oral surgery at the School of
Dentistry, Cardiff, United Kingdom or from patients attend-
ing the Wound Healing Clinic at the University Hospital of
Wales, Cardiff, United Kingdom. Patients with diabetes, sys-
temic immunosuppression, or evidence of local infection
were excluded from the study.
Establishment of oral mucosa, chronic wound, and
patient-matched normal fibroblasts
Cultures were established by a single-cell suspension tech-
nique following enzymatic degradation of the specimens as
previously described.1 The population doublings (PDs) of the
cell populations (n = 4 OMF/NF1 and n = 4 CWF/NF2) in
vitro were derived from direct counting of cell numbers at
each passage.
Affymetrix gene expression microarray analysis
RNAwas extracted from serum-stimulated cells as described.12
Briefly, cells (passage 5 or 6) were seeded at a density of
1 × 104 cells/cm2 in 10 cm diameter dishes and cultured for 24
hours. Cells were then serum starved for 48 hours to induce
quiescence. Cells were then restimulated with serum and har-
vested at 0 and 6 hours (the time point where maximal fibro-
blast response has been previously shown following serum
activation12) and RNA was extracted. RNA concentration was
quantified on a Genequant pro spectrophotometer (GE Health-
care Life Science, Little Chalfont, Bucks, United Kingdom) by
measuring the absorbance at 260 nm. RNAintegrity was deter-
mined using an RNA nanoLabChip kit on an Agilent 2100
bioanalyzer (Agilent Technologies, Workingham, Berks,
United Kingdom). Samples (n = 4 OMF/NF1 and n = 4 CWF/
NF2) were labeled and hybridized to Affymetrix GeneChips
(U133A) by the Central Biotechnology Service, Cardiff Uni-
versity. After scanning and probe-level quality control assess-
ment, expression summary values were extracted using the
MAS 5.0 algorithm. Expression of a number of the genes
assessed using these GeneChips was corroborated by quanti-
tative polymerase chain reaction (Supporting Information
Figure S1).Asingle GeneChip was used for each experimental
condition. However, the data for the 6-hour sample in skin of
one patient was found to be an outlier during probe-level
quality control analysis, and thus the 0-hour and 6-hour data
from this sample was excluded from all further analysis. Thus,
for subsequent continuum analysis, a 30-GeneChip dataset
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Figure 1. An overview of the cellular and clinical characteris-
tics of the functional wound healing continuum. Key pro-
cesses associated with scarless, scarring, and nonhealing
wound repair are highlighted as they increase and decline
across the repair spectrum. Critical to this is the role of the
fibroblast and the “aging” transition from fetal fibroblasts,
through adult fibroblasts to senescent fibroblasts.
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was used that comprised the 0-hour and 6-hour expression data
from the four OMF samples and four CWF samples, together
with the 0-hour and 6-hour data from their patient-matched
normal fibroblasts (NF1 and NF2).
Continuum analysis
The aim of the continuum analysis was to identify serum
responsive genes whose expression were found to be either
greatest in OMF and decreased in NF1 and NF2 to CWF, or
conversely were lowest in OMF and then showed increased
levels in NF1 and NF2 to CWF. Each of the ∼22,000 probe sets
was analyzed individually. For each probe set, all 112 possible
subsets were selected that comprised the matched 0-hour and
6-hour data for one OMF, one NF, and one CWF sample. Each
subset was then assessed for its “compliance/fit” with a series
of hypothetical gene profiles reflective of either enhanced
wound healing (Figure 2, top) or dysfunctional wound healing
(Figure 2, bottom). A subset was scored as having a “con-
tinuum pattern” if it matched the following criteria. First, there
was a minimum of a twofold change in expression level in
response to serum in the NF pair and either or both of the CWF
and OMF. Second, a correlation coefficient of 0.7 or greater to
one of the hypothetical profiles was required. The direction of
the continuum gradient was defined as either increasing
(OMF < NF < CWF) or decreasing (OMF > NF > CWF). For
each probe set, the number of the 112 subsets where the data
were scored as matching the continuum was recorded. Statis-
tical probability was then determined by a permutation-based
test where 10,000 random subsets were created for each probe
set, each made by selecting three random 0-hour/6-hour pairs
but ignoring the tissue type. For each probe set, the number of
times it was scored as a continuum gene in the 112 subsets was
then compared with the number of times it was scored as a
continuum gene in the 10,000 random subsets. A p-value was
then generated using a chi-square test. Probe sets with a false
discovery rate (FDR) corrected p-value of <0.05 were selected.
These probes were then annotated and analyzed by
overrepresentation analysis using the Database forAnnotation,
Visualization and Integrated Discovery (DAVID) version 6.7
(www.david.abcc.ncifcrf.gov). Gene Ontology (GO) biologi-
cal process (GOTERM_BP_ALL) categories that were iden-
tified (p < 0.05) as overrepresented were then ranked by
Expression Analysis of Systematic Explorer (EASE) score.
Probe sets were then classified as having an ascending or
descending pattern based on being in a particular group when
at least one quarter of the samplings matched for one or more
of the continuums (continuum patterns as laid out in Figure 2),
resulting in the final enhanced healing and dysfunctional
healing gene sets.
RESULTS
Fibroblasts show a continuum of
proliferative potential
To illustrate the concept of a continuum of cellular responses
between OMF, NF, and CWF, the growth kinetics of these
cells were investigated through senescence. OMF had the
greatest proliferative potential, proliferating for much longer
in culture and senescing later than patient-matched NF1
(mean of 101.5 PD vs. 56.8 PD, respectively; p < 0.02;
Figure 3). Conversely, CWF had the least proliferative poten-
tial, growing for a much shorter period of time in culture and
senescing earlier than patient-matched NF2 (mean of 18.04
PD vs. 48.03 PD, respectively; p < 0.02). A comparison of
NF1 (head/neck) with NF2 (thigh) showed a similar growth
potential (p > 0.2). Therefore, for further analysis, three
“sets” will be considered: OMF (four patient samples), NF
(seven patient samples; 3× head/neck [one of the four samples
failed quality control, see above] and 4× thigh), and CWF
(four patient samples).
Defining a gene signature for differential
wound healing
We used a permutation-based test to identify probe sets that
were differentially expressed in OMF, NF, and CWF in a
‘ENHANCED HEALING’ continuum gene expression patterns
0h 6h 0h 6h 0h 6h
OMF
(n=4)
CWF
(n=4)
NF
(n=7)
‘DYSFUNCTIONAL HEALING’ continuum gene expression patterns
Figure 2. The “continuum” patterns of gene expression
investigated. A sampling was noted as having a “continuum
pattern” if there was a minimum twofold change in expression
level in response to serum in at least the normal (middle)
and one of the “ends” of the continuum, and a correlation
coefficient of 0.7 or greater to either a positive or negative
continuum gradient. The continuum gradient was defined as
either increasing (OMF < NF < CWF) or decreasing (OMF >
NF > CWF). CWF, chronic wound fibroblast; NF, normal skin
fibroblast; OMF, oral mucosal fibroblast.
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Figure 3. The growth potential of fibroblasts isolated from
adult oral mucosal, adult skin, and adult chronic venous leg
ulcer tissues (n = 4 OMF; n = 7 NF1/NF2; n = 4 CWF). CWF,
chronic wound fibroblast; NF, normal skin fibroblast; OMF, oral
mucosal fibroblast; PDL, population doubling level.
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pattern consist with a possible role in a wound healing con-
tinuum (i.e., those demonstrating an increasing [OMF <
NF < CWF] or decreasing [OMF > NF > CWF] expression
gradient from one “end” of the continuum to the other). For
the differential fibroblast populations, all possible sampling
of one OMF sample, one NF sample, and one CWF sample
(giving the 112 different samplings of the dataset) were
assessed for correlation of this subset to the theoretical
profiles of a healing continuum (Supporting Information
Figure S2). A total of 112 probe sets displayed patterns of
expression consistent with that of an ideal continuum (Sup-
porting Information Figure S3; FDR controlled p < 0.05) and
were further subdivided into ascending or descending con-
tinuum patterns. The largest group of genes identified by this
continuum identification analysis was the enhanced healing
group (Figure 4A and Supporting Information Table S2),
which showed a descending pattern of expression across the
continuum. Sixty-six genes were present within this group,
and although they have diverse functions, they do have the
common characteristic of having their highest expression in
the fetal-like (scarless) oral mucosa and decreasing to their
lowest levels in the impaired nonhealing phenotype of the
chronic wound (example shown in Figure 5A and C). Thirty-
eight genes were present within the dysfunctional healing
group (Figure 4B and Supporting Information Table S3) and
were at low levels in cells where healing was enhanced and
were at increased levels in cells associated with poor wound
healing capacities (example shown in Figure 5B and D). One
gene (MYLIP) showed a more complex pattern of expression
and fell into more than one of the gene expression pattern
classifications.
Functional analysis of the gene signature
Overrepresentation analysis was carried out on the continuum
gene set using GO and DAVID EASE to identify functional
classifications that were enriched. Within the complete con-
tinuum gene set, several functional categories were overrep-
resented, including a large representation for the role for
development/differentiation and their regulation. Further-
more, several categories of relevance to wound healing and
aging (Supporting Information Table S4) were also identified
including “regulation of cell proliferation,” which was the
OMF 0h NF 0h CWF 0h OMF 6h NF 6h CWF 6h A OMF 0h NF 0h CWF 0h OMF 6h NF 6h CWF 6h B
Figure 4. Expression heat map of
“enhanced healing” (A) and “dysfunc-
tional healing” (B) groups of genes
arranged to highlight the gradient of
expression from top to bottom of the
continuum at 0 hour and 6 hours time
points. This heat map was generated by
mapping the data onto a light-dark
range representing low–high expres-
sion levels, respectively. CWF, chronic
wound fibroblast; NF, normal skin fibro-
blast; OMF, oral mucosal fibroblast.
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Figure 5. Pattern of expression of genes present within the
“enhanced healing” (A) and “dysfunctional healing” (B)
groups. Examples of relative gene expression from each of
these two groups are shown (C & D respectively; open
bars = 0-hour samples, closed bars = 6-hour samples). Bone
morphogenetic protein 2 (BMP2) and neuroepithelial cell trans-
forming gene 1 (NET1) were chosen to represent examples of
(1) a gene linked to enhanced/preferential healing (i.e., BMP2
stimulated significantly in OMF [scarless] but not CWF
[nonhealing]); and (2) a gene linked to dysfunctional/chronic
healing (i.e., NET1 stimulated in CWF [nonhealing] but not
OMF [scarless]). CWF, chronic wound fibroblast; NF, normal
skin fibroblast; OMF, oral mucosal fibroblast.
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most significantly overrepresented category in this gene
set. Overrepresentation of the “response to wounding” and
“wound healing” functional pathways in addition to other
wound healing-related categories including cell migration and
its regulation, growth factor signalling pathways, angiogen-
esis, cell–cell signalling, categories associated with response
to stress and extracellular stimuli, BMP signalling pathways,
apoptosis, and the positive regulation of gene expression were
all shown. Of specific interest with respect to tissue repair,
chemokine ligand (CXCL)-1 and 6, platelet-derived growth
factor receptor, alpha polypeptide (PDGFRA), fibroblast
growth factor (FGF)-5 and 18, coagulation factor III, and
BMP2 were identified within the enhanced wound healing
gene set (Supporting Information Table S2), whereas the
wound healing-related genes SERPINE1, FGF1, and
interleukin-1 beta (IL-1β) were shown within the dysfunc-
tional wound healing gene set (Supporting Information
Table S3).
DISCUSSION
This study has identified group of continuum genes that were
further subdivided with respect to which particular pattern of
continuum-like expression they display, namely, those which
show “descending” or “ascending” patterns of expression
across the continuum. Those genes whose expression dimin-
ished across the continuum (i.e., OMF > NF > CWF) may be
associated with a positive, enhanced, or effective wound
healing phenotype (which will be referred to hereafter as the
enhanced healing group). Alternatively, those genes whose
expression increased across the same continuum were likely
to be associated with a negative or impaired wound healing
phenotype (which will be referred to hereafter as the dysfunc-
tional healing group). Theoretically, the analysis could have
been undertaken utilizing a different sequence, but the above
one was specifically chosen to link to the distinctly different
wound healing potentials of the source tissues from which the
cells (with such distinct phenotypes) were sourced.
The expression analysis presented here has shown that
genes associated with a number of processes including key
components of the wound healing response are differentially
regulated by serum (a surrogate wound healing stimulus) in a
manner which varies depending upon the source of fibroblasts
being studied. The wound healing capacities of these different
fibroblast populations can be matched to the “top,” “middle,”
and “bottom” of the age-related wound healing continuum,
and a number of genes have shown patterns of differential
expression, which are associated with either a decreasing
(enhanced wound healing) or an increasing (dysfunctional
wound healing) continuum pattern. Other processes, less
directly linked to wound healing, were also found to corre-
spond to this continuum pattern, specifically those relating to
system and organ development, developmental regulation,
and morphogenesis. This therefore is further confirmation of
the previous reported similarities between some elements of
the tissue repair and tissue development pathways.
Age-related biological effects in impaired/delayed wound
healing have been shown when comparing aged vs. young
individuals in both human and animal models.17,18 This “age-
related” differential capacity for wound healing is also found
in cells (e.g., fibroblasts) isolated from different locations on
the same individual.8,10,15 Within this study, several character-
istics of these different cell populations (OMF, NF, and CWF)
mirror those seen across an aging healing continuum (most
significantly their differential capacity for effective wound
healing and their observed differences in proliferative poten-
tial). The replicative capacity of fibroblasts has been shown to
reduce with age, which is associated with a reduction in
growth factor responsiveness19 and the increased production
of markers of replicative senescence.20
Effective wound healing depends upon the action and inter-
action of thousands of genes taking part in a number of key
biological processes. A number of the genes present within
the described continuum wound healing profile have been
previously noted to alter expression in different biological
wound models and in an age-related manner. Such observa-
tions validate our approach and suggest that it is relevant to
dissect some aspects of the continuum of wound healing.
These and other genes in the profile are associated with path-
ways and processes linked to determining the effectiveness of
the wound healing response (e.g., genes associated with cell
proliferation and growth factor pathways, cell migration, cell
signaling, chemotaxis, in addition to genes functionally asso-
ciated with wound healing).
Of the enhanced healing genes identified by this analysis,
CXC chemokines CXCL1 and CXCL6 are of particular inter-
est in wound healing biology due the crucial role of inflam-
mation during the process. CXCL1 is thought to initiate
neutrophil recruitment immediately after injury.21 Reduced
induction of these CXC chemokines within chronic wounds
may be indicative of a reduced ability to induce an acute
inflammatory response. Gene coagulation factor III is also
associated with the inflammatory phase of the wound healing
response, and increased expression is known to result in
enhanced wound healing.22 Reducing levels of enhanced gene
PDGFRA expression, across the continuum may partially
explain these previously noted reductions in responsiveness to
PDGF observed with increased aging23 and in cells isolated
from chronic wounds.24
Of those wound healing genes found within the “dysfunc-
tional” continuum signature, the proinflammatory cytokine
IL-1β is known to mediate important functions in the
early and late courses of inflammation, trauma, and wound
healing.25 SERPINE1 (plasminogen activator inhibitor-1
[PAI-1]) expression has been noted to increase with age26 and
is an essential mediator of replicative senescence.27 PAI-1 is
also known to be a key component of the transcriptional
response to wounding in epithelial cells.28
The study of gene expression at a genome-wide level can
be utilized to gain insight into specific biological processes
and diseases. Among the most heavily examined examples of
such studies are those targeted at cancer. In this field, tran-
scriptional profiling has led to the identification of gene
expression signatures for classification of disease stage/state,
clinical outcome, and response to therapy.29–31 Indeed, a
serum-induced fibroblast gene signature has been used as a
predictive indicator for clinical outcome prediction in mul-
tiple types of cancer.13
However, microarray analysis of (human) skin and wound
healing has yet to reach this point of application. Microarray
technology has been utilized to examine normal and wounded
human skin across a number of patients,11,32,33 and expression
in healthy and wounded skin has also been compared with
that of in vitro models.34 Studies have also compared the
expression profiles of healing and scarring tissues of both
humans and multiple animal models.35 Analysis of human
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oral mucosal wound healing expression profiles36 has been
complemented by comparisons of the gene expression pro-
files of similar (scarless) oral mucosal wounds and (scarring)
skin wounds of pigs and humans.37 The expression profiles of
fetal skin wounds in the early (scarless healing) and late (scar
forming) gestational periods of rats were also compared.38
Microarray-based gene expression analysis of a time series of
the acute wound healing response has also been undertaken in
rats.39 Early in vitro analysis of the transcriptional response of
human fibroblasts to serum showed that it mirrored many
aspects of the normal wound healing response.12 Comparison
of fetal and adult fibroblasts from multiple anatomical sites
indicated that gene expression differed both following serum
starvation and also in response to serum stimulation.8 Among
those genes was fibroblast growth factor 18, a gene which is
part of the enhanced healing profile described here. Similarly,
while all the genes were not in common, distinct similarities
were observed between the functional categories overrepre-
sented in this study with those reported by others in fibro-
blasts in response to serum (e.g., cell motility, extracellular
matrix remodeling, cell–cell signaling, cell proliferation, and
angiogenesis8).
A gene profile for nonhealing venous leg ulcers has been
reported based on tissue samples taken from the wound bed
and wound edge of patients with healing and nonhealing
chronic venous leg ulcers.11 These investigators suggested that
such an approach may have implications for the development
of novel therapies and prognostic indicators for wound
healing. Further comparisons of gene profiles from chronic
venous leg ulcers and healthy, unwounded skin showed that
differentiation and activation markers were deregulated in the
nonhealing samples.11 In another investigation, Brem et al.10
determined that the nonhealing edge of venous leg ulcers and
the corresponding adjacent normal skin also had distinct and
reproducible gene expression signatures and that fibroblasts
isolated from these two sites differed in morphology and
capacity to repair wounds in support of our own findings.4
These investigations have, for the first time, identified a
novel gene signature for differential wound healing across the
entire spectrum of the repair process.Aprofile of 104 genes has
been identified, some of which have previously identified
functions in wound healing and some of which appear to be
novel in this area. This analysis gives insight into some of the
genes that may be involved in (and possibly determine) the
effectiveness of the wound healing process in a particular acute
or chronic wound environment. Further analysis of the expres-
sion of some/all of these signature genes may assist in the
determination of the healing potential of the cells/sample/
patient under investigation. While the purpose of this investi-
gation was to specifically assess gene expression in relation to
wound healing outcome (which technologically could be com-
mercially translatable), future analysis of protein data and
investigation within the tissues themselves to confirm such
functional wound healing difference would add a further,
interesting dimension to this analysis.Afurther potential thera-
peutic value of this signature will be in the assessment of the
effectiveness of a wound healing therapy through monitoring
changes in the expression of those genes over time in patients.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Figure S1. Gene-matched quantitative polymerase
chain reaction (qPCR) data and Affymetrix (Affy) microarray
data from n = 3 independent patients for a number of genes
demonstrating the validity and robustness of the microarray
data (note the similar expression profiles across the different
samples [NF and CWF] and time points [0 and 6 hours]).
Values = mean (n = 3) ± standard error of the mean (SEM).
CWF, chronic wound fibroblast; CXCL, chemokine ligand;
NF, normal skin fibroblast.
Figure S2. Schematic of the continuum analysis meth-
odology. One hundred twelve samplings were possible (four
OMF × seven NF1/NF2 × four CWF) with each assessed for
its “compliance/fit” with a wound healing continuum. To
account for the possibility of a probe set following the desired
expression pattern by chance, data were also randomly
sampled. CWF, chronic wound fibroblast; NF, normal skin
fibroblast; OMF, oral mucosal fibroblast.
Figure S3. Expression heat map of continuum-like
genes.
Table S1. Tissue details for each OMF, NF, and CWF
cell strain.
Table S2. A list of genes expressed during enhanced
wound healing obtained from analysis of the microarray data.
Table S3. A list of genes expressed during dysfunctional
wound healing obtained from analysis of the microarray data.
Table S4. Functional classification of wound healing
continuum genes.
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